Mayo Clinic Tapestry 2.0: Applying Multi-Omics for Scientific Discovery
NCT06456320 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2025-10-16
Summary
The purpose of this study is to use multi-omics testing on samples collected from Mayo Clinic patients to build and expand on what has been learned about genomic data.
Conditions
- Genetic Predisposition
- Exposure, Environmental
Sponsors & Collaborators
- lead OTHER
Principal Investigators
-
Konstantinos N. Lazaridis, M.D. · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-05
- Primary Completion
- 2027-12-31
- Completion
- 2027-12-31
Countries
- United States
Study Locations
More Related Trials
-
Study of DNA Samples From Patients With Multiple Myeloma
NCT00898040 ·Status: COMPLETED
-
Exploring the Landscape of Somatic Mutations in Human Tissue
NCT06585800 ·Status: ENROLLING_BY_INVITATION
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Study of DNA Copy Numbers Variations and Gene Expression Profile of Bone Marrow Plasma Cells From MGUS and SMM.
NCT01079429 ·Status: TERMINATED
-
Molecular and ctDNA Characterization of High-Risk Endometrial Cancer
NCT07062016 ·Status: RECRUITING
-
Cancer Genetic Testing in Ethnic Populations
NCT04475640 ·Status: RECRUITING ·Phase: NA
-
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
NCT02253251 ·Status: RECRUITING
-
SMS 2: Impact of Cancer Therapy on the Somatic Mutational Landscape of Normal Tissues
NCT06832150 ·Status: ENROLLING_BY_INVITATION
-
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
NCT04456140 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Study of Plasma Genotyping as a Noninvasive Biomarker for Genotype-directed Cancer Care
NCT02279004 ·Status: ACTIVE_NOT_RECRUITING
-
Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal
NCT05530759 ·Status: RECRUITING
-
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
NCT00283530 ·Status: TERMINATED
-
Clinical Sequencing of Cancer and Tissue Repository: OncoGenomics
NCT03027401 ·Status: WITHDRAWN
-
The Aim is to Identify Recurrent Genomic Mutations and/or Predisposing Polymorphisms in Patients With Sporadic Cases of Multiple Myeloma
NCT05331313 ·Status: UNKNOWN
-
Microscopy Imaging of Whole-mount Stained Human Tissues
NCT05689112 ·Status: RECRUITING
-
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
NCT01454297 ·Status: COMPLETED
-
Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing
NCT01556828 ·Status: TERMINATED
-
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
NCT06008392 ·Status: RECRUITING
-
Optical Genome Mapping in Characterization of Multiple Myeloma
NCT05786105 ·Status: COMPLETED
-
Role of Gut Microbiome in Cancer Therapy
NCT05112614 ·Status: RECRUITING
-
Prospective Registry of Multiplex Testing (PROMPT)
NCT02665195 ·Status: ACTIVE_NOT_RECRUITING
-
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
NCT04955808 ·Status: SUSPENDED
-
Identification of Biomarkers for Patients with Vascular Anomalies
NCT03001180 ·Status: RECRUITING
-
Use of Exome Sequence Analysis and Circulating Tumour in Assessing Tumour Heterogeneity in BRAF Mutant Melanoma
NCT02251314 ·Status: COMPLETED
-
Genomic and Proteomic Profiling Targets Influenced Treatment in Metastatic Breast Cancer
NCT02470819 ·Status: WITHDRAWN ·Phase: NA